232 related articles for article (PubMed ID: 10225286)
1. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
Hormozi K; Parton R; Coote J
FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286
[TBL] [Abstract][Full Text] [Related]
2. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
Hormozi K; Parton R; Coote J
Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
[TBL] [Abstract][Full Text] [Related]
3. Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins.
Westrop G; Hormozi K; da Costa N; Parton R; Coote J
J Bacteriol; 1997 Feb; 179(3):871-9. PubMed ID: 9006045
[TBL] [Abstract][Full Text] [Related]
4. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
Orr B; Douce G; Baillie S; Parton R; Coote J
Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
[TBL] [Abstract][Full Text] [Related]
6. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro.
Westrop GD; Hormozi EK; Da Costa NA; Parton R; Coote JG
Gene; 1996 Nov; 180(1-2):91-9. PubMed ID: 8973351
[TBL] [Abstract][Full Text] [Related]
8. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
Khosravani A; Parker MC; Parton R; Coote J
Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
[TBL] [Abstract][Full Text] [Related]
9. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C
Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
[TBL] [Abstract][Full Text] [Related]
10. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
Lim A; Ng JK; Locht C; Alonso S
Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
[TBL] [Abstract][Full Text] [Related]
11. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system.
Sebo P; Glaser P; Sakamoto H; Ullmann A
Gene; 1991 Jul; 104(1):19-24. PubMed ID: 1916273
[TBL] [Abstract][Full Text] [Related]
12. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
Lee SJ; Gray MC; Guo L; Sebo P; Hewlett EL
Infect Immun; 1999 May; 67(5):2090-5. PubMed ID: 10225859
[TBL] [Abstract][Full Text] [Related]
14. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.
Gross MK; Au DC; Smith AL; Storm DR
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
Arciniega JL; Hewlett EL; Edwards KM; Burns DL
FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
[TBL] [Abstract][Full Text] [Related]
16. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.
Boyd AP; Ross PJ; Conroy H; Mahon N; Lavelle EC; Mills KH
J Immunol; 2005 Jul; 175(2):730-8. PubMed ID: 16002668
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
[TBL] [Abstract][Full Text] [Related]
18. Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli.
Benz R; Maier E; Ladant D; Ullmann A; Sebo P
J Biol Chem; 1994 Nov; 269(44):27231-9. PubMed ID: 7525549
[TBL] [Abstract][Full Text] [Related]
19. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin.
Iwaki M; Ullmann A; Sebo P
Mol Microbiol; 1995 Sep; 17(6):1015-24. PubMed ID: 8594322
[TBL] [Abstract][Full Text] [Related]
20. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL
J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
